Medical Communications

Showing 15 posts of 6411 posts found.

scale-403585_960_720

Weight loss pill treatment rejected by NICE

May 8, 2017 Medical Communications, Sales and Marketing NICE, orexigen

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …

NHS staff feeling the pay squeeze, reports NHS Providers

May 8, 2017 Medical Communications, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

Pfizer offers breast cancer drug for free following NICE rejection

May 5, 2017 Medical Communications, Sales and Marketing NICE, Pfizer

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …
exit-1722888_960_720

Regulus CEO heads to exit as company struggles with FDA hold

May 5, 2017 Medical Communications, Research and Development Regulus, hepatitis C

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …
talc_mine

J&J chalks up another defeat in $110 million talc-cancer case

May 5, 2017 Medical Communications Johnson & Johnson, baby powder

Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …
gsk_hq_logo

GSK boosts Benlysta production with $139 million investment

May 5, 2017 Manufacturing and Production, Medical Communications GSK

GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …
european_commission_web

European Commission warns UK over drug authorisation validity due to Brexit

May 4, 2017 Medical Communications, Sales and Marketing EMA, European Commission, brexit

The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017 Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …
roche

Roche denies its acne treatment led to suicide of 21 year old

May 4, 2017 Medical Communications, Sales and Marketing Roaccutane, Roche

Last month, Luke Reeves took his own life at the age of just 21. Prior to his death, he had …
shutterstock_243110086

Real-world data: High on the life science agenda

May 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …
scott_gottlieb

Scott Gottlieb enters final stage of approval for FDA Commissioner role

April 28, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, scotrt gottlieb

Trump’s pick for the top job in the FDA moved one step closer to taking up the job when the …
pills_spill

Cancer Drug Fund roundly criticised as ‘wastage of resources’

April 28, 2017 Medical Communications Cancer Drug Fund, Conservative, NHS, NICE, UK

The Cancer Drug Fund (CDF), which has now been absorbed into NICE, previous methods of funding have been fiercely criticised …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …
bayer_cross_2

FDA approves first new drug for liver cancer in decade

April 28, 2017 Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …
The Gateway to Local Adoption Series

Latest content